Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
YD Bio Limited ( (YDES) ) just unveiled an update.
On January 16, 2026, YD Bio Limited disclosed that two majority shareholders, YD Biopharma Holding Limited and EG Biomed Limited, had delivered a written shareholder consent resulting in significant changes to the company’s board of directors. Effective December 30, 2025, four directors — Joe Douglas Ramsey, Albert Scott McLelland, Michaela Ann Griggs and Janet Hall — were removed, and two new directors, Dr. Kochi Chang and Dr. Shao-Da Lu, were appointed, signaling a shift in governance steered by controlling shareholders and potentially reshaping the company’s strategic direction through the addition of directors with extensive medical, dental, and healthcare leadership backgrounds.
The most recent analyst rating on (YDES) stock is a Hold with a $11.50 price target. To see the full list of analyst forecasts on YD Bio Limited stock, see the YDES Stock Forecast page.
Spark’s Take on YDES Stock
According to Spark, TipRanks’ AI Analyst, YDES is a Neutral.
The score is driven primarily by weak financial performance (losses, negative margins, and negative operating/free cash flow), partially offset by low balance-sheet leverage. Technical indicators add downside pressure with the price below key moving averages and a negative MACD, while valuation provides limited support due to loss-making earnings and no dividend.
To see Spark’s full report on YDES stock, click here.
More about YD Bio Limited
YD Bio Limited is a Taiwan-based biopharmaceutical company, listed in the United States as a foreign private issuer, operating from Taipei. While this filing does not detail its specific product lines, the company is positioned within the broader life sciences and healthcare sector and is subject to U.S. securities regulation under Form 20-F reporting requirements.
Average Trading Volume: 80,437
Technical Sentiment Signal: Buy
Current Market Cap: $832.2M
For a thorough assessment of YDES stock, go to TipRanks’ Stock Analysis page.